1st Circ. Affirms Dismissal Of Investor's Biogen Suit
The First Circuit on Thursday affirmed the dismissal of an investor lawsuit alleging biopharmaceutical company Biogen Inc. downplayed the impact a patient death had on sales, saying the supposedly misleading statements...To view the full article, register now.
Already a subscriber? Click here to view full article